ESSA’s mCRPC drug EPI-7386 has positive clinical effects, stock prices soar
ADC评论
October 28, 2022
On October 26, ESSA Pharma announced the latest positive results from the first two cohorts of the company’s lead drug candidate EPI-7386 in combination with
